The cellular immune responses induced in the follow-up of interferon-α treated patients with chronic hepatitis C may determine the therapy outcome

Journal of Hepatology

Volumn 29, Issue 4, 1998, Pages 524-532

  Löhr, Hanns F ^a   Gerken, Guido ^a   Roth, Michael ^a   Weyer, Sandra ^a   Schlaak, Jörg F ^a   Meyer Zum Büschenfelde, Karl Hermann ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Chronic hepatitis C; HCV core and nonstructural antigens; HCV genotypes; Immunopathogenesis; Interferon ; T cells; Viral clearance; Viral load

Indexed keywords

ALPHA INTERFERON; HELICASE;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HELPER CELL; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME; VIREMIA; VIRUS INFECTION; VIRUS LOAD;

EID: 0032191747     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80146-3     Document Type: Article

References (38)

1. 1. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of disease. Hepatology 1991; 14: 381-8.
2. 2. Fernandez I, Castellano G, Domingo MJ, Fuertes A, Colina F, Canga F, et al. Influence of viral genotype and level of viremia on the severity of liver injury and the response to interferon therapy in Spanish patients with chronic C infection. Scand J Gastroenterol 1997; 32: 70-6.
3. 3. Picciotto A, Campo N, Brizzolara R, Sinelli N, Poggi G, Grasso S, et al. HCV-RNA levels play an important role independently of genotype in predicting response to interferon therapy. Eur J Gastroenterol Hepatol 1997; 9: 67-9.
4. 4. Okanoue T, Yasui K, Sakamoto S, Minami M, Nagao Y, Itoh Y, et al. Circulating HCV-RNA, HCV genotype, and liver histology in asymptomatic individuals reactive for anti-HCV antibody and their follow-up study. Liver 1996; 16: 241-7.
5. 5. Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995; 95: 2067-75.
6. 6. Imada K, Fukuda Y, Koyama Y, Nakano I, Yamada M, Katano Y, et al. Naive and memory T cell infiltrates in chronic hepatitis C: phenotypic changes with interferon treatment. Clin Exp Immunol 1997; 109: 59-66.
7. 7. Di Bisceglie AM, Hoofnagle JH, Krawczynski K. Changes in hepatitis C virus antigen in liver with antiviral therapy. Gastroenterology 1993; 105: 858-62.
8. 8. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995; 95: 521-30.
9. 9. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996; 98: 1432-40.
10. 10. Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178: 17-25.
11. 11. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104: 580-7.
12. 12. Schupper H, Hayashi P, Scheffel J, Aceituno S, Paglieroni T, Holland PV, et al. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology 1993; 18: 1055-60.
13. 13. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, et al. T-and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology 1996; 24: 790-5.
14. 14. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 1006-7.
15. 15. Giuberti T, Marin MG, Ferrari C, Marchelli S, Schianchi C, Degli Antoni AM, et al. Hepatitis C virus viremia following clinical resolution of acute hepatitis C. J Hepatol 1994; 20: 666-71.
16. 16. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994; 19: 286-95.
17. 17. Gerken G, Knolle P, Jakobs S, Meyer zum Büschenfelde K-H. Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment. Arch Virol 1997; 142: 459-64.
18. 18. Stuyver L, Rossau R, Wyseur A, Dzuhamel LM, Vanderborght B, van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1105-13.
19. 19. Lörh HF, Schlaak JF, Kollmannsperger S, Dienes HP, Meyer zum Büschenfelde KH, Gerken G. Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. Liver 1996; 16: 174-82.
20. 20. Diepolder HM, Gerlach JT, Zachoval R, Hoffmann RM, Jung MC, Wierenga EA, et al. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 1997; 71: 6011-9.
21. 21. Artini M, Nisini R, Missale G, Costanzo A, Accapezzato D, Balsano C, et al. Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes. Viral Immunol 1995; 8: 63-73.
22. 22. Löhr HF, Goergen B, Meyer zum Büschenfelde KH, Gerken G. HCV replication in mononuclear cells stimulates anti-HCV-secreting B cells and reflects nonresponsiveness to interferon-alpha. J Med Virol 1995; 46: 314-20.
23. 23. Appasamy R, Bryant J, Hassanein T, Van Thiel DH, Whiteside TL. Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C. Clin Immunol Immunopathol 1994; 73: 350-7.
24. 24. Löhr HF, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Meyer zum Büschenfelde KH. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994; 14: 161-6.
25. 25. Napoli J, Bishop GA, McGuiness PH, Painter DM, McGaughan GW. Progressive liver injury in chronic hepatitis C virus infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24: 759-65.
26. 26. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997; 25: 449-58.
27. 27. Iwata K, Wakita T, Okumura A, Yoshioka K, Takayanagi M, Wands JR, et al. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 1995; 22: 1057-64.
28. 28. Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 1997; 159: 1012-8.
29. 29. Sugiyama K, Kato N, Mizutani T, Ikeda M, Tanaka T, Shimotohno K. Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T cells. J Gen Virol 1997; 78: 329-36.
30. 30. Quian C, Camps J, Maluenda MD, Civeira MP, Prieto J. Replication of the hepatitis C virus in peripheral blood mononuclear cells. J Hepatol 1992; 16: 380-3.
31. 31. Löhr HF, Elste C, Dienes HP, Michel G, Braun HB, Meyer zum Büschenfelde KH, et al. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha. J Hepatol 1996; 25: 292-300.
32. 32. Löhr H, Nagel C, Dienes HP, Simpson B, Michel G, Goergen B, et al. Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha. Hepatology 1994; 20: 1383-9.
33. 33. Pawlotsky JM, Darthuy F, Remire J, Pellet C, Udin L, Stuyver L, et al. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C. J Med Virol 1995; 47: 285-91.
34. 34. Ando Y, Sonnerborg A, Barkholt L, Birkett A, Ericzon BG, Sallberg M. Antibody production against hepatitis C virus core and nonstructural 3 proteins is highly sensitive to deficits in T-cell function. Clin Diagn Lab Immunol 1997; 4: 104-6.
35. 35. Yoshioka K, Aiyama T, Okumura A, Takayanagi M, Iwata K, Ishikawa T, et al. Humoral immune response to the hyper-variable region of hepatitis C virus differs between genotypes 1b and 2a. J Infect Dis 1997; 175: 505-10.
36. 36. Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 1997; 25: 697-701.
37. 37. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 35-6.
38. 38. Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR. Induction of a CD8+cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 1997; 186: 65-70.